기본 정보
- CAS
478296-72-9- 표준 SMILES
CC(OC(=O)NCC1(CC(=O)O)CCCCC1)OC(=O)C(C)C- InChIKey
TZDUHAJSIBHXDL-UHFFFAOYSA-N- 분자식
- C16H27NO6
- 평균 분자량
- 329.39 g/mol
- 단동위원소 질량
- 329.18383758
개요
Gabapentin enacarbil is a carbamate ester that is the N-[1-(isobutyryloxy)ethoxy]carbonyl derivative of [1-(aminomethyl)cyclohexyl]acetic acid. The prodrug for gabapentin, used for treatment of neuropathic pain and restless legs syndrome. It has a role as an anticonvulsant, a calcium channel blocker and a prodrug. It is a carbamate ester, a monocarboxylic acid, a carboxylic ester and an acetal. It is functionally related to a gamma-aminobutyric acid and a gabapentin.
이름 및 식별자
- 우선 이름
- Gabapentin Enacarbil
- IUPAC
- 2-[1-[[1-(2-methylpropanoyloxy)ethoxycarbonylamino]methyl]cyclohexyl]acetic acid
- 현지명
- 가바펜틴에나카르빌
- 영어명
- Gabapentin enacarbil
- 분자식
- C16H27NO6
- 분자량
- 329.39
이름 및 동의어
이름 더 보기
데이터베이스 식별자
- CAS
478296-72-9- PubChem CID
- 9883933
- DTXSID
DTXSID30870359- ChEMBL
CHEMBL1628502- ChEBI
CHEBI:68840- UNII
- 75OCL1SPBQ
- EC Number
- 620-082-7
- Nikkaji
- J3.209.908D
물성
구조 계산 물성
- XLogP
- 3.1
- 극성 표면적
- 102 Ų
- 수소 결합 공여자 수
- 2
- 수소 결합 수용자 수
- 6
- 회전 가능 결합 수
- 9
- 무거운 원자 수
- 23
- 형식 전하
- 0
- 복잡도
- 428
실험 및 물리화학적 성질
Human Drugs
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
물리화학적 성질
- 녹는점
- 65 °C · 65 °C
- 끓는 점
- 482 · 482.0±20.0 °C(Predicted)
- 밀도
- 1.134 · 1.134
- 저장 조건
- -20 °C · Store at -20°C
- 용해도
- 100 · DMSO:100.0(Max Conc. mg/mL);303.59(Max Conc. mM)Ethanol:100.0(Max Conc. mg/mL);303.59(Max Conc. mM)Water:0.67(Max Conc. mg/mL);2.03(Max Conc. mM)
- 물리적 상태
- 가루
- 산도 계수 (pKa)
- 4.72 · 4.72±0.10(Predicted)
- 색상
- Light yellow to brown
- InChI
- InChI=1S/C16H27NO6/c1-11(2)14(20)22-12(3)23-15(21)17-10-16(9-13(18)19)7-5-4-6-8-16/h11-12H,4-10H2,1-3H3,(H,17,21)(H,18,19)
- InChIKey
- TZDUHAJSIBHXDL-UHFFFAOYSA-N
- SMILES
- C1(CNC(OC(OC(=O)C(C)C)C)=O)(CC(O)=O)CCCCC1
안전 및 규제
GHS 분류
GHS Classification
This chemical does not meet GHS hazard criteria for 100% (2 of 2) of all reports.
Not Classified
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory.
유해성 정보
독성 정보
Hepatotoxicity
In prelicensure clinical trials, gabapentin enacarbil was not linked to an increased rate of serum enzyme elevations during treatment or to episodes of clinically apparent acute liver injury. Gabapentin has been implicated in isolated cases of acute liver injury, but in most instances the association was weakened by the coadministration with other potentially hepatotoxic agents. Too few cases have been reported in sufficient detail to characterize the clinical features of the associated injury. No published case has specifically implicated gabapentin enacarbil. Thus, gabapentin enacarbil may be associated with isolated instances of clinically apparent liver injury, but they must be rare, if they occur at all.
Drug Induced Liver Injury
Drug Induced Liver Injury Rank (DILIrank 2.0)
Gabapentin enacarbil
vNo-DILI-concern
0
No match
DOI:10.1016/j.drudis.2016.02.015
안전 데이터
- wgk
- WGK 3
- 스토리지 클래스
- 11 - Combustible Solids
화학 및 산업
약리 정보
FDA Pharmacological Classification
GABAPENTIN ENACARBIL
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Absorption, Distribution and Excretion
Gabapentin enacarbil is absorbed in the intestines by active transport through the proton-linked monocarboxylate transporter, MCT-1.
Gabapentin enacarbil is eliminated primarily in the urine (94%) and to a lesser extent in the feces (5%).
The volume of distribution is 76L.
Renal clearance of gabapentin is 5 to 7 L/hr.
응용 분야
개요Gabapentin enacarbil (GEn) is an actively transported prodrug of gabapentin that provides sustained doseproportional exposure to gabapentin and predictable bioavailability. In April 2011, Gabapentin enacarbil is approved by the US Food and Drug Administration for the treatment of moderate-to-severe primary restless legssyndrome (RLS) in adults.Gabapentin enacarbil was designed to be recognized as a substrate for two high-capacity nutrient transports, monocarboxylate transporter type 1 and sodium-dependent multivitamin transporter, and to be efficiently cleaved after absorption to give gabapentin. The separated enantiomers of gabapentin enacarbil have similar cleavage rates in human tissues. Preclinical studies showed that gabapentin enacarbil provides good systemic exposure of gabapentin in rats and monkeys.
용도Gabapentin enacarbil (HORIZANT GlaxoSmithKline/XenoPort) is a prodrug of gabapentin used as an anticonvulsant as well as a treatment for neurogenic pain, with the same mechanism of action as pregabalin.
공급사81 곳
추가 설명
정의ChEBI: A carbamate ester that is the N-[1-(isobutyryloxy)ethoxy]carbonyl derivative of [1-(aminomethyl)cyclohexyl]acetic acid. The prodrug for gabapentin, used for treatment of neuropathic pain and restless legs syndrome.
관련 반응
화합물 노트
불러오는 중…